作者: Alejandro Paredes , Julián Vega , Ana de León , Andrés Kanacri , Pablo Castro
DOI: 10.4067/S0034-98872013001200010
关键词:
摘要: The assessment of patients with a suspected cardiac failure aims to an early and precise diagnosis risk stratification. Only natriuretic peptides have demonstrated be clinically useful. Brain peptide stands out due its diagnostic prognostic value. However results should cautiously interpreted in the clinical context, bearing mind possible confounders. combination markers can provide better stratification compensates limitations individual markers. Each new marker gives insight on underlying physiopathology proposes therapeutic approaches.